Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFα) and activated neutrophils in isolated perfused rabbit lungs

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 1, 1998, Pages 89-94

  Miyazaki, Y ^a   Inoue, T ^a   Kyi, Min ^a   Sawada, M ^a   Miyake, S ^a   Yoshizawa, Y ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; SIVELESTAT; SODIUM CHLORIDE; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; ISOLATED LUNG; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0031938112     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.1.9612021     Document Type: Article

References (32)

1. Weiss, S. T. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
2. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:552-559.
3. Smedley, L. A., M. G. Tonnesen, C. H. Sandhaus, and G. S. Worthen. 1986. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J. Clin. Invest. 77:1233-1243.
4. Esmon, C. T., and W. G. Owen. 1981. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. U.S.A. 78:2249-2252.
5. Dittman, W. A., and P. W. Majerus. 1990. Structure and function of thrombomodulin: a natural anticoagulant. Blood 75:329-336.
6. Takano, S., S. Kimura, S. Ohdama, and N. Aoki. 1990. Plasma thrombomodulin in health and diseases. Blood 76:2024-2029.
7. Iwashima, Y., T. Sato, K. Watanabe, and I. Marino. 1990. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39:983-988.
8. Ohdama, S., S. Takano, S. Miyake, S. Kubota, K. Sato, and N. Aoki. 1994. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular disease. Am. J. Clin. Pathol. 101:109-113.
9. Kawabata, K., M. Suzuki, M. Sugitani, K. Imaki, M. Toda, and K. Miyamoto. 1991. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. 177:814-820.
10. Yamazaki, S., E. Onishi, K. Enami, K. Natori, M. Kohase, H. Sakamoto, M. Tanouchi, and H. Hayashi. 1986. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Japan. J. Med. Sci. Biol. 39:105-118.
11. Uchiyama, H., H. Ohtani, H. Hiraishi, S. Horie, and M. Kazama. 1992. Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced disseminated intravascular coagulation and the effect of heparin. Thromb. Res. 65:593-604.
12. Lindahl, L., A. Ljungman, R. Bruhn, R. Hede, and C. Tagesson. 1991. Calcium ionophore-activated neutrophils prestimulated with endotoxin increase pulmonary arterial pressure and vascular leakage in isolated perfused rat lungs: role of platelet-activating factor. Experimental Lung Research 17:77-89.
13. Patterson, C., J. Bernard, J. Lafuze, M. Hull, and R. Rhoades. 1989. The role of activation of neutrophils and microvascular pressure in acute pulmonary edema. Am. Rev. Respir. Dis. 140:1052-1062.
14. Shasby, D. M., K. M. Vanbenthuysen, R. M. Tate, S. S. Shasby, and J. E. Repine. 1982. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am. Rev. Respir. Dis. 123:443-447.
15. Lo, S. K., J. Everitt, J. Gu, and A. B. Malik. 1992. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest. 89:981-988.
16. Mulligan, M. S., M. L. Jones, A. A. Vaporciyan, and P. A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151:5666-5674.
17. Tsukimoto, K., N. Yoshimura, M. Ichioka, N. Tojo, and J. B. West. 1994. Protein, cell, and LTB4 concentrations of lung edema fluid produced by high capillary pressures in rabbit. J. Appl. Physiol. 76:321-327.
18. Ismail, G., M. L. Morganroth, R. F. Todd, III, and L. A. Boxer. 1987. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincuhated with anti-Mol monoclonal antibody. Blood 69:1167-1174.
19. Sakamaki, F., A. Ishizaka, T. Urano, K. Sayama, H. Nakamura, T. Terashima, Y. Waki, S. Tasaka, N. Hasegawa, K. Sato, N. Nakagawa, T. Obata, and M. Kanazawa. 1996. Effect of specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 153:391-397.
20. Michie, H. R., K. R. Manogue, D. R. Spriggs, R. Revhaug, S. O. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
21. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Harri, T. J. Fahey, III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
22. Damas, P., A. Reuter, P. Gysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17:975-978.
23. Roten, R., M. Markert, F. Feihl, M. Shaller, M. Tagan, and C. Perret. 1991. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 143:590-592.
24. Gibbs, L. S., L. Lai, and A. B. Malik. 1990. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J. Cell Physiol. 145:496-500.
25. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
26. Carpenter, L. J., K. J. Johnson, R. G. Kunkel, and R. A. Roth. 1987. Phorbol myristate acetate produces injury to isolated rat lungs in the presence and absence of perfused neutrophils. Toxicol. Appl. Pharmacol. 91:22-32.
27. 4-induced lung injury in rabbit. J. Appl. Physiol. 76:91-96.
28. Kubo, K., T. Kobayashi, T. Hayano, T. Koizumi, T. Honda, M. Sekiguchi, and A. Sakai. 1994. Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. J. Appl. Physiol. 77:1333-1340.
29. Esmon, C. T. 1989. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:4743-4746.
30. Dittman, W. A., T. K. Kumada, J. E. Sadler and P. W. Majerus. 1988. The structure and function of mouse thrombomodulin: phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J. Biol. Chem. 263: 15815-15822.
31. Moore, K. L., C. T. Esmon, and N. L. Esmon. 1989. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159-165.
32. McDonald, R. J., E. M. Berger, and J. E. Repine. 1987. Neutrophil-derived oxygen metabolites stimulate thromboxane release, pulmonary artery pressure increases, and weight gains in isolated perfused rat lungs. Am. Rev. Respir. Dis. 135:957-959.